STOCK TITAN

Astera Labs officer Germaine Cota sells 35 shares

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
4

Rhea-AI Filing Summary

Astera Labs, Inc. officer Germaine Cota reported selling 35 common shares on November 16, 2026, to satisfy tax-withholding obligations connected with the vesting and settlement of restricted stock units. The issuer had elected in advance to require automatic “sell to cover” sales; they were not discretionary trades. Reported prices were weighted averages for block trades involving multiple security holders.

Insider Cota Germaine
Role Chief Accting. Off. & VP, Fin.
Sold 35 shs ($7K)
Type Security Shares Price Value
Sale Common Stock F1, F2, F3 2 $209.6586 $419.32
Sale Common Stock F1, F4 5 $208.7492 $1K
Sale Common Stock F1, F5 7 $207.8707 $1K
Sale Common Stock F1, F6 6 $206.7493 $1K
Sale Common Stock F1, F7 5 $205.9011 $1K
Sale Common Stock F1, F8 6 $204.8121 $1K
Sale Common Stock F1, F9 3 $203.8384 $611.52
Sale Common Stock F1, F10 1 $201.895 $201.90
Holdings After Transaction: Common Stock — 26,505 shares (Direct)
Footnotes (10)
  1. F1. Represents shares of the Issuer's Common Stock required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Such sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a "sell to cover", and does not represent a discretionary trade by the Reporting Person.
  2. F2. The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $209.3050 to $210.3000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in these footnotes.
  3. F3. Includes 100 shares acquired under the Astera Labs, Inc. 2024 Employee Stock Purchase Plan on November 13, 2026.
  4. F4. The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $208.3000 to $209.2950, inclusive.
  5. F5. The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $207.3000 to $208.2950, inclusive.
  6. F6. The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $206.3000 to $207.2900, inclusive.
  7. F7. The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $205.3000 to $206.2900, inclusive.
  8. F8. The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $204.2850 to $205.2750, inclusive.
  9. F9. The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $203.3000 to $204.2750, inclusive.
  10. F10. The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $201.3800 to $202.2700, inclusive.
Common shares sold 35 shares Reported sales on November 16, 2026, to satisfy tax-withholding obligations.
Weighted-average price, 2-share sale $209.6586 per share Reported sale on November 16, 2026; the footnote describes the price as a weighted average.
Weighted-average price, 1-share sale $201.8950 per share Reported sale on November 16, 2026; the footnote describes the price as a weighted average.
Shares acquired under employee stock purchase plan 100 shares Acquired under Astera Labs’ 2024 Employee Stock Purchase Plan on November 13, 2026.
sell to cover financial
"funded by a “sell to cover”"
Sell to cover is when a person who receives company stock through options or awards sells just enough shares immediately to pay required taxes, exercise costs, or fees, keeping the rest. Think of it like cashing part of a bonus to cover the tax bill so you can keep the remainder. For investors, it can create predictable small selling pressure and slightly change the number of shares actually held by insiders without increasing long‑term dilution.
restricted stock units financial
"vesting and settlement of restricted stock units"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
weighted average price financial
"The price reported in Column 4 is a weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
block trades financial
"sold as part of block trades for multiple security holders"
A block trade is a single, large buy or sell of shares or bonds arranged privately between big traders rather than piecemeal on the public market. Think of it like buying a whole shipment at once instead of many small shopping trips; it lets large holders move big positions with less immediate disruption but can signal strong buying or selling pressure and cause price swings once the trade is known, so investors watch block trades for clues about market sentiment and liquidity.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many ALAB shares did Germaine Cota sell?

Germaine Cota, Chief Accting. Off. & VP, Fin., reported sales of 35 shares to satisfy tax withholding on November 16, 2026. The sales were automatic under an issuer election made in advance and were not discretionary; the reported prices were weighted averages for block trades involving multiple holders.

How many shares did Germaine Cota acquire under Astera Labs’ employee stock purchase plan?

A footnote states that the reported share amount includes 100 shares acquired under Astera Labs’ 2024 Employee Stock Purchase Plan on November 13, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Cota Germaine

(Last)(First)(Middle)
C/O ASTERA LABS, INC.
2345 NORTH FIRST STREET

(Street)
SAN JOSE CALIFORNIA 95131

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Astera Labs, Inc. [ ALAB ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Chief Accting. Off. & VP, Fin.
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
11/16/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock11/16/2026S(1)2D$209.6586(2)26,538(3)D
Common Stock11/16/2026S(1)5D$208.7492(4)26,533D
Common Stock11/16/2026S(1)7D$207.8707(5)26,526D
Common Stock11/16/2026S(1)6D$206.7493(6)26,520D
Common Stock11/16/2026S(1)5D$205.9011(7)26,515D
Common Stock11/16/2026S(1)6D$204.8121(8)26,509D
Common Stock11/16/2026S(1)3D$203.8384(9)26,506D
Common Stock11/16/2026S(1)1D$201.895(10)26,505D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Represents shares of the Issuer's Common Stock required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Such sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a "sell to cover", and does not represent a discretionary trade by the Reporting Person.
2. The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $209.3050 to $210.3000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in these footnotes.
3. Includes 100 shares acquired under the Astera Labs, Inc. 2024 Employee Stock Purchase Plan on November 13, 2026.
4. The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $208.3000 to $209.2950, inclusive.
5. The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $207.3000 to $208.2950, inclusive.
6. The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $206.3000 to $207.2900, inclusive.
7. The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $205.3000 to $206.2900, inclusive.
8. The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $204.2850 to $205.2750, inclusive.
9. The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $203.3000 to $204.2750, inclusive.
10. The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $201.3800 to $202.2700, inclusive.
Remarks:
/s/ Philip Mazzara, Attorney-in-Fact11/18/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading